AB0 blood group and prognosis in patients with pancreatic cancer

作者: Nuh N Rahbari , Ulrich Bork , Ulf Hinz , Albrecht Leo , Johanna Kirchberg

DOI: 10.1186/1471-2407-12-319

关键词:

摘要: Although blood group 0 is associated with a reduced risk of pancreatic cancer, little known about the role AB0 antigens in disease progression. We assessed prognostic relevance status large cohort patients resected cancer. A total 627 patients, who underwent resection for ductal adenocarcinoma between October 2001 and December 2008 were enrolled. The relationship outcome was analyzed using univariate multivariate Cox regression analyses. In cancer incidence (31%) lower compared to 13.044 without (38%) (p = 0.0005). There no significant differences clinicopathologic characteristics among different groups. 3-year 5-year overall survival rates 29% 14%. On analysis did not correlate (p = 0.39). Multivariate analysis, however, revealed favorable independent impact on (Hazard ratio 0.78; 95% confidence interval 0.62 – 0.99; p = 0.037). independently prognosis

参考文章(54)
Nuh N. Rahbari, Nathan Mollberg, Moritz Koch, John P. Neoptolemos, Jürgen Weitz, Markus W. Büchler, Surgical Resection for Pancreatic Cancer Springer New York. pp. 971- 996 ,(2010) , 10.1007/978-0-387-77498-5_39
Vogel F, Controversy in human genetics. ABO blood groups and disease. American Journal of Human Genetics. ,vol. 22, pp. 464- 475 ,(1970)
R. Manna, G. Gambassi, V. Annese, M. Minervini, A. Gabbrielli, ABO blood groups and cancer of the pancreas. International Journal of Pancreatology. ,vol. 6, pp. 81- 88 ,(1990) , 10.1007/BF02933042
Anna Maria Witkowska, Maria Halina Borawska, Soluble intercellular adhesion molecule‐1 (sICAM‐1): an overview European Cytokine Network. ,vol. 15, pp. 91- 98 ,(2004)
B C Del Villano, S Brennan, P Brock, C Bucher, V Liu, M McClure, B Rake, S Space, B Westrick, H Schoemaker, V R Zurawski, Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clinical Chemistry. ,vol. 29, pp. 549- 552 ,(1983) , 10.1093/CLINCHEM/29.3.549
Joseph A. Buckwalter, ABO BLOOD GROUPS AND DISEASE Journal of the American Medical Association. ,vol. 162, pp. 1210- 1215 ,(1956) , 10.1001/JAMA.1956.02970300010005
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
Donald M. Marcus, The ABO and Lewis Blood-Group System New England Journal of Medicine. ,vol. 280, pp. 994- 1006 ,(1969) , 10.1056/NEJM196905012801806
Tohru Nakagoe, Atsushi Nanashima, Terumitsu Sawai, Takashi Tuji, Masayuki Ohbatake, Masaaki Jibiki, Hiroyuki Yamaguchi, Toru Yasutake, Hiroyoshi Ayabe, Tatsuki Matuo, Yutaka Tagawa, Expression of blood group antigens A, B and H in carcinoma tissue correlates with a poor prognosis for colorectal cancer patients. Journal of Cancer Research and Clinical Oncology. ,vol. 126, pp. 375- 382 ,(2000) , 10.1007/PL00008485
J. Magnani, M Brockhaus, D. Smith, V Ginsburg, M Blaszczyk, K. Mitchell, Z Steplewski, H Koprowski, A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science. ,vol. 212, pp. 55- 56 ,(1981) , 10.1126/SCIENCE.7209516